Literature DB >> 12612868

Worsening renal function: what is a clinically meaningful change in creatinine during hospitalization with heart failure?

Grace L Smith1, Viola Vaccarino, Mikhail Kosiborod, Judith H Lichtman, Susan Cheng, Suzanne G Watnick, Harlan M Krumholz.   

Abstract

INTRODUCTION: Worsening renal function during hospitalization for heart failure, defined as elevation in creatinine during admission, predicts adverse outcomes. Prior studies define worsening renal function using various creatinine elevations, but the relative value of definitions is unknown. METHODS AND
RESULTS: In a prospective cohort of 412 patients hospitalized for heart failure, we compared a spectrum of worsening renal function definitions (absolute creatinine elevations >/=0.1 to >/=0.5 mg/dL and 25% relative elevation from baseline) and associations with 6-month mortality, readmission, and functional decline. Creatinine elevation >/=0.1 mg/dL occurred in 75% of patients, and elevation >/=0.5 mg/dL occurred in 24% of patients. Risk of death rose with higher creatinine elevations (adjusted hazard ratio [HR] = 0.89, 1.19, 1.67, 1.91, and 2.90 for elevations >/=0.1 to >/=0.5 mg/dL). Maximum sensitivity of any definition for predicting mortality was 75% and maximum specificity was 79%. High creatinine elevation was a more important predictor of death than was a single measure of baseline creatinine.
CONCLUSIONS: Larger creatinine elevations predict highest risk of death, yet even minor changes in renal function are associated with adverse outcomes. The choice of a "best definition" for worsening renal function has implications for the number of patients identified with this risk factor and the magnitude of risk for mortality.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12612868     DOI: 10.1054/jcaf.2003.3

Source DB:  PubMed          Journal:  J Card Fail        ISSN: 1071-9164            Impact factor:   5.712


  81 in total

1.  Worsening renal function defined as an absolute increase in serum creatinine is a biased metric for the study of cardio-renal interactions.

Authors:  Jeffrey M Testani; Brian D McCauley; Jennifer Chen; Michael Shumski; Richard P Shannon
Journal:  Cardiology       Date:  2010-08-03       Impact factor: 1.869

2.  The conundrum of worsening renal function and optimal volume status in patients with acute decompensated heart failure.

Authors:  Theo E Meyer; Jeffrey Shih
Journal:  Curr Heart Fail Rep       Date:  2010-12

Review 3.  Pathophysiology and clinical evaluation of acute heart failure.

Authors:  Robert J Mentz; Christopher M O'Connor
Journal:  Nat Rev Cardiol       Date:  2015-09-15       Impact factor: 32.419

4.  Cystatin C-based CKD-EPI equations and N-terminal pro-B-type natriuretic peptide for predicting outcomes in acutely decompensated heart failure.

Authors:  Pedro J Flores-Blanco; Sergio Manzano-Fernández; Juan I Pérez-Calvo; Francisco J Pastor-Pérez; Francisco J Ruiz-Ruiz; Francisco J Carrasco-Sánchez; José L Morales-Rull; Domingo Pascual-Figal; Luis Galisteo-Almeda; James L Januzzi
Journal:  Clin Cardiol       Date:  2015-02-06       Impact factor: 2.882

5.  Temporal variations in hematocrit values in patients with left ventricular dysfunction: Relationship with cause-specific mortality and morbidity and optimal monitoring--further insights from SOLVD.

Authors:  Simon de Denus; Jean-Claude Tardif; Michel White; Martial G Bourassa; Normand Racine; Sylvie Levesque; Anique Ducharme
Journal:  Can J Cardiol       Date:  2008-01       Impact factor: 5.223

6.  Comorbid Heart Failure and Renal Impairment: Epidemiology and Management.

Authors:  Pupalan Iyngkaran; Merlin Thomas; William Majoni; Nagesh S Anavekar; Claudio Ronco
Journal:  Cardiorenal Med       Date:  2012-10-31       Impact factor: 2.041

7.  Targeting the kidney in acute heart failure: can old drugs provide new benefit? Renal Optimization Strategies Evaluation in Acute Heart Failure (ROSE AHF) trial.

Authors:  Horng H Chen; Omar F AbouEzzeddine; Kevin J Anstrom; Michael M Givertz; Bradley A Bart; G Michael Felker; Adrian F Hernandez; Kerry L Lee; Eugene Braunwald; Margaret M Redfield
Journal:  Circ Heart Fail       Date:  2013-09-01       Impact factor: 8.790

8.  Furosemide responsiveness, non-adherence and resistance during the chronic treatment of heart failure: a longitudinal study.

Authors:  Robert J MacFadyen; J Christopher Gorski; D Craig Brater; Allan D Struthers
Journal:  Br J Clin Pharmacol       Date:  2004-05       Impact factor: 4.335

Review 9.  Epidemiology and importance of renal dysfunction in heart failure patients.

Authors:  Gregory Giamouzis; Andreas P Kalogeropoulos; Javed Butler; Georgios Karayannis; Vasiliki V Georgiopoulou; John Skoularigis; Filippos Triposkiadis
Journal:  Curr Heart Fail Rep       Date:  2013-12

10.  Empirical relationships among oliguria, creatinine, mortality, and renal replacement therapy in the critically ill.

Authors:  Tal Mandelbaum; Joon Lee; Daniel J Scott; Roger G Mark; Atul Malhotra; Michael D Howell; Daniel Talmor
Journal:  Intensive Care Med       Date:  2012-12-07       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.